Positive Test Boosts Sanofi (France) MS Drug Hopes

CAMBRIDGE, Mass June 1, 2012 - Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE…
Read the full story: BioSpace.com Featured News